AVECTAS Leads EUR7.23 million Consortium Awarded Part Funding From Disruptive Technologies Innovation Fund
Dublin (ots/PRNewswire) - Funding to develop high throughput cell engineering technology to manufacture 'off the shelf' cell therapies. Project, led by Avectas in partnership with Bluebridge Technologies and National Institute for Bioprocessing Research and Training (NIBRT), would support Ireland's goal of being at ...